Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics

Abstract

It is feasible to extend the interval between doses of AAT to 14 or 21 days to achieve adequate trough total AAT concentrations. This study might be used as a starting point for clinical evaluation of the regimens described.